Key facts
- La Renon Healthcare’s last known valuation is $1.2B.
- It has raised $116.1M; the latest was Secondary Transaction - Private ($124.5M) in Nov 2025.
- Notable investors include Peak XV Partners, A91 Partners, Siguler Guff, White Oak Capital Management, Avendus Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for La Renon Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for La Renon Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About La Renon Healthcare
Operator of a healthcare company intended to treat chronic illnesses and diseases. The company operates in chronic segments of nephrology, neurological disorders, critical care, gynecology, ortho, gastroenterology, urology, respiratory and cardio-metabolic diseases, enabling healthcare professionals to treat their patients and improve their lives.
- Sector
- Healthcare
- HQ
- Ahmedabad, India
- Founded
- 2007
- Employees
- 4,000
- Website
- larenon.com/
- Ownership
- Privately Held (backing)
La Renon Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in La Renon Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on La Renon Healthcare in its N-PORT filings yet. We sweep new filings monthly.